Large-conductance Ca2+-activated K+ (BK) channels control a range of physiological functions, and their dysfunction is linked to human disease. We have found that the widely used drug loperamide (LOP) can inhibit activity of BK channels composed of either α-subunits (BKα channels) or α-subunits plus the auxiliary γ1-subunit (BKα/γ1 channels), and here we analyze the molecular mechanism of LOP action. LOP applied at the cytosolic side of the membrane rapidly and reversibly inhibited BK current, an effect that appeared as a decay in voltage-activated BK currents. The apparent affinity for LOP decreased with hyperpolarization in a manner consistent with LOP behaving as an inhibitor of open, activated channels. Increasing LOP concentration reduced the half-maximal activation voltage, consistent with relative stabilization of the LOP-inhibited open state. Single-channel recordings revealed that LOP did not reduce unitary BK channel current, but instead decreased BK channel open probability and mean open times. LOP elicited use-dependent inhibition, in which trains of brief depolarizing steps lead to accumulated reduction of BK current, whereas single brief depolarizing steps do not. The principal effects of LOP on BK channel gating are described by a mechanism in which LOP acts as a state-dependent pore blocker. Our results suggest that therapeutic doses of LOP may act in part by inhibiting K+ efflux through intestinal BK channels.
State-dependent inhibition of BK channels by the opioid agonist loperamide
M.A. Jacobson’s present address is Evotec (US) Inc., Princeton, NJ.
- Award Group:
- Funder(s): National Institutes of Health
- Award Ids(s): R01 GM126581,R01 NS078152
- Views Icon Views
- Share Icon Share
- Search Site
Alexandre G. Vouga, Michael E. Rockman, Jiusheng Yan, Marlene A. Jacobson, Brad S. Rothberg; State-dependent inhibition of BK channels by the opioid agonist loperamide. J Gen Physiol 6 September 2021; 153 (9): e202012834. doi: https://doi.org/10.1085/jgp.202012834
Download citation file: